Test Price
2,800 AED✅ Home Collection Available
RIMS1 Gene Cone-Rod Dystrophy Type 7 Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
The RIMS1 gene sequencing test using next-generation technology delivers 99.9% diagnostic sensitivity for cone-rod dystrophy type 7. This ISO-accredited assay is supported by temperature-controlled home phlebotomy, post-test clinical guidance, and direct insurance verification via WhatsApp +971 54 548 8731.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next-generation sequencing test analyzes the entire coding region of the RIMS1 gene to detect pathogenic mutations causing cone-rod dystrophy type 7, a progressive inherited retinal disorder leading to vision loss. Early genetic confirmation enables tailored ophthalmic surveillance, family planning, and access to emerging therapies.
| Feature | Our Test (RIMS1 NGS) | Alternative (Sanger / Clinical Dx) |
|---|---|---|
| Precision | 99.9% sensitivity for all RIMS1 variants | Limited to known mutations; may miss novel variants |
| Method | Illumina NGS with full bioinformatics pipeline | Capillary electrophoresis; lower throughput |
| Speed | 3–4 Weeks | 4–6 Weeks for single gene |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I recognize that receiving a diagnosis of cone-rod dystrophy can be overwhelming for patients and families. This test provides definitive molecular clarification, but results must always be interpreted in the full context of clinical history, family pedigree, and ophthalmologic findings. Genetic counseling is essential both before and after testing to ensure comprehensive understanding and informed decision-making.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
This genetic test provides diagnostic and predictive information but does not replace ongoing clinical management. Patients should continue all prescribed treatments and follow-up appointments with their ophthalmologist. Any concerns about vision changes should be addressed immediately with a medical professional.
Exclusion Criteria & ER Red Flags
- Exclusion Criteria: None for standard venipuncture; patients with severe coagulopathy or bleeding disorders must inform the phlebotomy team before sample collection.
- ER Red Flags: If you experience sudden, severe vision loss, acute eye pain, flashes of light, or a curtain-like shadow over your vision, seek emergency ophthalmologic care immediately. This genetic test is not a substitute for urgent clinical evaluation.
Patient FAQ & Clinical Guidance
1. What does the RIMS1 gene test detect, and why is it essential?
This test detects pathogenic mutations in the RIMS1 gene associated with cone-rod dystrophy type 7, a condition causing progressive vision impairment. Early genetic confirmation enables tailored ophthalmic surveillance, family planning, and access to emerging therapies. It is the definitive molecular diagnosis for affected individuals and at-risk relatives.
2. How long do results take and how are they delivered?
Results are typically available within 3 to 4 weeks and are delivered via secure electronic report with optional telephone clinical guidance. The report includes variant interpretation, clinical significance, and recommendations for further management. A genetic counseling session can be scheduled upon request.
3. Is genetic counseling included, and what are the sample requirements?
A pre-test genetic counseling session is mandatory to draw a pedigree and discuss implications before sample collection, which can be whole blood, extracted DNA, or one drop of blood on an FTA card. Post-test counseling is also available to help families understand the results and inheritance patterns. Our coordinators will arrange home collection if you choose the VIP phlebotomy service.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with UAE federal data protection and healthcare regulations. All genetic data is handled under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our DHA-licensed facility (License No. 1143) follows stringent protocols for data encryption, access control, and secure disposal of biological specimens.
Clinical & Logistical Metadata
| Test Name | RIMS1 Gene Cone-Rod Dystrophy Type 7 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood (3–5 mL in EDTA tube), extracted DNA, or dried blood spot on FTA card |
| Methodology Used | Next-Generation Sequencing (Illumina NGS) with full bioinformatics pipeline |
| ICD-10-CM Code | H35.52 |
| LOINC Code | 55233-1 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians